Type a word to start your search

Loading

Innovative approach for the development of probiotics capsules with enhanced stability.

Health is more important than ever as a concern for the population. The aging demographic and the emergence of new diseases demand innovative solutions. Despite their significant potential in addressing these issues, probiotics remain generally inaccessible for many due to high production costs. For over 10 years, the collaboration between CNETE and the Quebec-based company Bio-K+, a Canadian subsidiary specializing in probiotics from the global leader in health and nutrition, Kerry Group, has led to the development of numerous products and industrial transfers. They aim to continue this fruitful and highly effective collaboration through a project that will develop new probiotic tablets incorporating functional natural ingredients while reducing production costs, thus improving their beneficial effects and accessibility.

The goal is to produce stable probiotic capsules at room temperature by integrating novel natural ingredients that have never been tested for this application, adding potential additional health benefits. By combining the expertise of CNETE and Kerry Canada, the project will explore the protective potential of these products to enhance survival during drying and storage stability of probiotics. The success of this work will demonstrate Quebec’s excellence in the field of industrial bioprocesses on the global stage. In partnership with a renowned international company, it will showcase the strength of the Quebec research ecosystem.

Joshua Cloutier-Beaupré

Centre national en électrochimie et en technologies environnementales (CNETE)

CRIBIQ's contribution

$ 82 016


Partners

Industrial participants :

Bio-K+, division Kerry

QPRI*
*Quebec public research institutes :

CNETE